EUVIMEDEUVIMED entdecken
Crossref

Site-specific glycosylation and single amino acid substitution dramatically reduced the immunogenicity of β-lactoglobulin

Michio Endo, Tadashi Yoshida, Keisatoi Ishii, Taku Iwamoto, Mamoru Totsuka, Makoto Hattori

Bioscience, Biotechnology, and Biochemistry · 21.03.2023 · 87 (4) · 426-433

DOI: 10.1093/bbb/zbac210 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioscience, Biotechnology, and Biochemistry, online erschienen am 28.12.2022. Verfasst von Michio Endo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Applied Biological Science, Tokyo University of Agriculture and Technology, Tokyo, Japan. Hauptthemen laut MEDLINE: Lactoglobulins, Mannose. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben. Gefördert von: JSPS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To reduce the immunogenicity of β-lactoglobulin (BLG), we prepared recombinant BLG which has both site-specific glycosylation and single amino acid substitution (D28N/P126A), and expressed it in the methylotrophic yeast Pichia pastoris by fusion of the cDNA to the sequence coding for the α-factor signal peptide from Saccharomyces cerevisiae. Sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS–PAGE) analysis indicated that the D28N/P126A was conjugated with a ∼4 kDa high-mannose chain. D28N/P126A retained ∼61% of the retinol-binding activity of BLG. Structural analyses by circular dichroism (CD) spectra, intrinsic fluorescence, and Enzyme-linked immunosorbent assay (ELISA) with monoclonal antibodies indicated that the surface structure of BLG was slightly changed by using protein engineering techniques, but D28N/P126A was covered by high-mannose chains and substituted amino acid without substantial disruption of native conformation. Antibody responses to the D28N/P126A considerably reduced in C57BL/6 mice. We conclude that inducing both site-specific glycosylation and single amino acid substitution simultaneously is an effective method to reduce the immunogenicity of BLG.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LactoglobulinsMannoseAnimalsMiceGlycosylationAmino Acid SubstitutionMice, Inbred C57BLSaccharomyces cerevisiae

Stichwörter der Autor:innen

neoglycoconjugateprotein engineeringreduced immunogenicitysingle amino acid substitutionβ-lactoglobulin

Substanzen

LactoglobulinsMannose

Autor:innen und Institutionen

  • Department of Applied Biological Science, Tokyo University of Agriculture and Technology, Tokyo, Japan.
  • Department of Applied Biological Chemistry, The University of Tokyo, Tokyo, Japan.

Förderung

  • JSPS

Zitieren

APA

Endo, M., Yoshida, T., Ishii, K., Iwamoto, T., Totsuka, M., & Hattori, M. (2023). Site-specific glycosylation and single amino acid substitution dramatically reduced the immunogenicity of β-lactoglobulin. Bioscience, Biotechnology, and Biochemistry, 87(4), 426-433. https://doi.org/10.1093/bbb/zbac210

Vancouver

Endo M, Yoshida T, Ishii K, Iwamoto T, Totsuka M, Hattori M. Site-specific glycosylation and single amino acid substitution dramatically reduced the immunogenicity of β-lactoglobulin. Bioscience, Biotechnology, and Biochemistry. 2023;87(4):426-433. doi:10.1093/bbb/zbac210

BibTeX
@article{Endo2023,
  author = {Endo, Michio and Yoshida, Tadashi and Ishii, Keisatoi and Iwamoto, Taku and Totsuka, Mamoru and Hattori, Makoto},
  title = {Site-specific glycosylation and single amino acid substitution dramatically reduced the immunogenicity of β-lactoglobulin},
  journal = {Bioscience, Biotechnology, and Biochemistry},
  year = {2023},
  volume = {87},
  number = {4},
  pages = {426--433},
  doi = {10.1093/bbb/zbac210}
}
Kostenlos starten →